Variant report

Variant	esv3330937
Chromosome Location	chr5:80255346-80257994
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:190)
CpG islands
(count:732)
Chromatin interactive
region (count:1)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:190 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr5:80255588-80256100	H1-hESC	embryonic stem cell:	n/a	n/a
2	BCL3	chr5:80255146-80256092	GM12878	blood:	n/a	n/a
3	BCL3	chr5:80255488-80255974	GM12878	blood:	n/a	n/a
4	CEBPB	chr5:80257653-80257965	HepG2	liver:	n/a	n/a
5	CEBPB	chr5:80257643-80257958	IMR90	lung:	n/a	n/a
6	CEBPB	chr5:80257649-80257909	A549	lung:	n/a	n/a
7	CHD1	chr5:80256711-80256898	H1-hESC	embryonic stem cell:	n/a	n/a
8	CHD1	chr5:80255766-80255951	H1-hESC	embryonic stem cell:	n/a	n/a
9	CREB1	chr5:80256401-80256642	A549	lung:	n/a	n/a
10	CREB1	chr5:80255584-80257085	HepG2	liver:	n/a	n/a
11	CTBP2	chr5:80255809-80257416	H1-hESC	embryonic stem cell:	n/a	n/a
12	CTCF	chr5:80257140-80257290	AG04450	lung:	n/a	n/a
13	CTCF	chr5:80256420-80256570	GM12875	blood:	n/a	n/a
14	CTCF	chr5:80256362-80256571	ProgFib	skin:	n/a	n/a
15	CTCF	chr5:80256320-80256470	GM12866	blood:	n/a	n/a
16	CTCF	chr5:80256420-80256570	HBMEC	blood vessel:	n/a	n/a
17	CTCF	chr5:80256681-80256774	GM12891	blood:	n/a	n/a
18	CTCF	chr5:80256040-80256190	SAEC	small airway:	n/a	n/a
19	CTCF	chr5:80256360-80256510	HFF	foreskin:	n/a	n/a
20	CTCF	chr5:80256380-80256530	SK-N-SH_RA	brain:	n/a	n/a
21	CTCF	chr5:80256320-80256470	AoAF	blood vessel:	n/a	n/a
22	CTCF	chr5:80256696-80256759	A549	lung:	n/a	n/a
23	CTCF	chr5:80256420-80256570	WERI-Rb-1	eye:	n/a	n/a
24	CTCF	chr5:80256340-80256490	AG09309	skin:	n/a	n/a
25	CTCF	chr5:80256380-80256530	HEK293	kidney:	n/a	n/a
26	CTCF	chr5:80256330-80256606	A549	lung:	n/a	n/a
27	CTCF	chr5:80256395-80256520	GM19240	blood:	n/a	n/a
28	CTCF	chr5:80256480-80256630	HMEC	breast:	n/a	n/a
29	CTCF	chr5:80256400-80256550	AG04449	skin:	n/a	n/a
30	CTCF	chr5:80256360-80256510	NHDF-neo	bronchial:	n/a	n/a
31	CTCF	chr5:80256340-80256490	HRPEpiC	eye:	n/a	n/a
32	CTCF	chr5:80256400-80256550	HUVEC	blood vessel:	n/a	n/a
33	CTCF	chr5:80256360-80256546	NHEK	skin:	n/a	n/a
34	CTCF	chr5:80256241-80256615	HepG2	liver:	n/a	n/a
35	CTCF	chr5:80256351-80256519	Kidney_OC	kidney:	n/a	n/a
36	CTCF	chr5:80256333-80256586	GM12891	blood:	n/a	n/a
37	CTCF	chr5:80256680-80256830	AG04449	skin:	n/a	n/a
38	CTCF	chr5:80256368-80256591	Fibrobl	skin:	n/a	n/a
39	CTCF	chr5:80256380-80256530	HAc	cerebellar:	n/a	n/a
40	CTCF	chr5:80256342-80256484	SK-N-SH_RA	brain:	n/a	n/a
41	CTCF	chr5:80256354-80256560	GM19238	blood:	n/a	n/a
42	CTCF	chr5:80256380-80256530	HFF-Myc	foreskin:	n/a	n/a
43	CTCF	chr5:80256360-80256510	HCM	heart:	n/a	n/a
44	CTCF	chr5:80256720-80256870	AG04449	skin:	n/a	n/a
45	CTCF	chr5:80256360-80256510	A549	lung:	n/a	n/a
46	CTCF	chr5:80256425-80256471	Pancreas_OC	pancreas:	n/a	n/a
47	CTCF	chr5:80256367-80256523	GM19239	blood:	n/a	n/a
48	CTCF	chr5:80256391-80256503	H1-hESC	embryonic stem cell:	n/a	n/a
49	CTCF	chr5:80256767-80256768	A549	lung:	n/a	n/a
50	CTCF	chr5:80256351-80256519	Spleen_OC	spleen:	n/a	n/a

(count:732 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:80256738-80256788	HAEpiC	amniotic membrane:	n/a
2	chr5:80256087-80256137	HCM	heart:	n/a
3	chr5:80256166-80256216	SK-N-MC	brain:	n/a
4	chr5:80256087-80256137	HRPEpiC	eye:	n/a
5	chr5:80256087-80256137	NHBE	bronchial:	n/a
6	chr5:80257322-80257372	GM12892	blood:	n/a
7	chr5:80257322-80257372	HMEC	breast:	n/a
8	chr5:80255793-80255843	BE2_C	brain:	n/a
9	chr5:80256535-80256585	HUVEC	blood vessel:	n/a
10	chr5:80257268-80257318	HCPEpiC	choroid plexus:	n/a
11	chr5:80256371-80256421	HIPEpiC	eye:	n/a
12	chr5:80256166-80256216	HIPEpiC	eye:	n/a
13	chr5:80255793-80255843	PFSK-1	brain:	n/a
14	chr5:80256137-80256187	SK-N-MC	brain:	n/a
15	chr5:80256738-80256788	HRE	kidney:	n/a
16	chr5:80256371-80256421	SK-N-MC	brain:	n/a
17	chr5:80256166-80256216	A549	lung:	n/a
18	chr5:80256971-80257021	HIPEpiC	eye:	n/a
19	chr5:80256664-80256714	HUVEC	blood vessel:	n/a
20	chr5:80255793-80255843	GM19239	blood:	n/a
21	chr5:80256137-80256187	H1-hESC	embryonic stem cell:	embryo
22	chr5:80257322-80257372	HIPEpiC	eye:	n/a
23	chr5:80256137-80256187	HAEpiC	amniotic membrane:	n/a
24	chr5:80256137-80256187	A549	lung:	n/a
25	chr5:80256371-80256421	HL-60	blood:	n/a
26	chr5:80256524-80256574	ovcar-3	ovarian:	n/a
27	chr5:80256535-80256585	HEK293	kidney:	embryo
28	chr5:80256137-80256187	RPTEC	kidney:	n/a
29	chr5:80256524-80256574	BE2_C	brain:	n/a
30	chr5:80256664-80256714	HNPCEpiC	eye:	n/a
31	chr5:80257322-80257372	HPAEpiC	pulmonary alveolar:	n/a
32	chr5:80256971-80257021	PrEC	prostate:	n/a
33	chr5:80256738-80256788	HCM	heart:	n/a
34	chr5:80256971-80257021	SAEC	small airway:	n/a
35	chr5:80256535-80256585	HL-60	blood:	n/a
36	chr5:80256166-80256216	NHDF-neo	bronchial:	n/a
37	chr5:80257322-80257372	A549	lung:	n/a
38	chr5:80255793-80255843	Caco-2	colon:	n/a
39	chr5:80257322-80257372	SK-N-SH_RA	brain:	n/a
40	chr5:80256535-80256585	IMR90	lung:	fetal
41	chr5:80256971-80257021	HL-60	blood:	n/a
42	chr5:80256535-80256585	MCF10A-Er-Src	breast:	n/a
43	chr5:80256738-80256788	NH-A	brain:	n/a
44	chr5:80255793-80255843	NT2-D1	testis:	n/a
45	chr5:80256535-80256585	HCPEpiC	choroid plexus:	n/a
46	chr5:80256738-80256788	HEK293	kidney:	embryo
47	chr5:80256738-80256788	HepG2	liver:	n/a
48	chr5:80256371-80256421	SKMC	muscle:	n/a
49	chr5:80256524-80256574	GM12878	blood:	n/a
50	chr5:80256371-80256421	K562	blood:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr5:80257641..80260093-chr5:80260267..80261887,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DHFR-2	chr5:80256600-80256726	ENSG00000251450.1
2	lnc-DHFR-2	chr5:80256150-80256189	XLOC_004907
3	lnc-DHFR-2	chr5:80256600-80256726	NR_105015

No data

Variant related genes	Relation type
RASGRF2	TF binding region
ENSG00000251450	TF binding region
RASGRF2	CpG island
ENSG00000251450	CpG island
CLSTN1	miRNA target sites

Extended variants
information (count: 104 )
Associated
traits (count: 79 )

Variant overlapped rSNPs/rCNVs (count:104 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs557064180	chr5:80255368-80255369	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs143704828	chr5:80255428-80255429	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs573545755	chr5:80255433-80255434	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs5869061	chr5:80255434-80255435	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs377546672	chr5:80255436-80255437	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs112046963	chr5:80255437-80255438	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs58471792	chr5:80255439-80255440	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs58221500	chr5:80255444-80255445	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs143261947	chr5:80255565-80255566	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs574962773	chr5:80255577-80255578	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs182301880	chr5:80255610-80255611	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs142202596	chr5:80255621-80255622	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs75826925	chr5:80255674-80255675	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs551464047	chr5:80255683-80255684	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs578158374	chr5:80255720-80255721	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs543912726	chr5:80255741-80255742	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs139012661	chr5:80255743-80255744	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs563839572	chr5:80255744-80255745	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs555239792	chr5:80255770-80255771	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs573804736	chr5:80255772-80255773	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs529229831	chr5:80255777-80255778	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs143147197	chr5:80255819-80255820	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs186296592	chr5:80255843-80255844	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
24	rs147487537	chr5:80255845-80255846	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs150807893	chr5:80255867-80255868	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs368408704	chr5:80255868-80255869	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs551656564	chr5:80255879-80255880	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs571350593	chr5:80255885-80255886	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs530771170	chr5:80255903-80255904	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs115261645	chr5:80255974-80255975	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs567381181	chr5:80255996-80255997	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs536372664	chr5:80256053-80256054	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs552966695	chr5:80256066-80256067	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs566480555	chr5:80256163-80256164	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
35	rs535335752	chr5:80256164-80256165	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
36	rs113829217	chr5:80256270-80256271	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs113077126	chr5:80256294-80256295	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs139949554	chr5:80256299-80256300	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs557294649	chr5:80256312-80256313	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs73123076	chr5:80256339-80256340	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs542721215	chr5:80256380-80256381	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs553018509	chr5:80256410-80256411	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
43	rs559273802	chr5:80256422-80256423	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs375975609	chr5:80256443-80256444	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs368584906	chr5:80256484-80256485	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs374422363	chr5:80256507-80256508	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs199546647	chr5:80256594-80256595	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
48	rs114321099	chr5:80256596-80256597	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
49	rs188573830	chr5:80256614-80256615	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	lncRNA	n/a	Overlapped CNVs	n/a
50	rs373681724	chr5:80256623-80256624	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:79)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Breast cancer	22032731	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Prostate cancer	21965145	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
Non-small cell lung cancer	21829676	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	19602461	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Merkel cell carcinoma	19020549	CNVD
Squamous cell cancer	20885788	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian cancer	21720365	CNVD
Acute myeloid leukemia	21251322	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Myelofibrosis	22110671	CNVD
craniofacial dysmorphism	21918468	CNVD
lymphocytic leukemia	21291569	CNVD
Lung cancer	16773561	CNVD
Multiple myeloma	16616336	CNVD
Testicular cancer	18059402	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16573809	CNVD

Chromatin state (count:459 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:80251600-80255800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
2	chr5:80252400-80255600	Enhancers	Cortex derived primary cultured neurospheres	brain
3	chr5:80252400-80255600	Weak transcription	Ovary	ovary
4	chr5:80252600-80255400	Enhancers	Primary T helper cells fromperipheralblood	blood
5	chr5:80252800-80255600	Enhancers	Primary T helper naive cells from peripheral blood	blood
6	chr5:80253000-80255400	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
7	chr5:80253200-80255400	Enhancers	Primary T killer memory cells from peripheral blood	blood
8	chr5:80253200-80255600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
9	chr5:80253200-80256000	Bivalent Enhancer	Fetal Thymus	thymus
10	chr5:80253400-80255400	Enhancers	Primary T cells fromperipheralblood	blood
11	chr5:80253400-80255800	Enhancers	Dnd41	blood
12	chr5:80253600-80255600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
13	chr5:80253600-80255600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
14	chr5:80253800-80255400	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
15	chr5:80254400-80255400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
16	chr5:80254400-80255600	Enhancers	HepG2	liver
17	chr5:80254800-80255600	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood
18	chr5:80254800-80255600	Bivalent Enhancer	Fetal Brain Male	brain
19	chr5:80255000-80255400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
20	chr5:80255000-80255600	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
21	chr5:80255000-80255800	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
22	chr5:80255000-80256000	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
23	chr5:80255000-80256000	Flanking Bivalent TSS/Enh	Primary T cells from cord blood	blood
24	chr5:80255200-80255400	Flanking Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
25	chr5:80255200-80255400	Flanking Active TSS	H9 Cell Line	embryonic stem cell
26	chr5:80255200-80255400	Flanking Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
27	chr5:80255200-80255400	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr5:80255200-80255400	Active TSS	Brain Angular Gyrus	brain
29	chr5:80255200-80255400	Active TSS	Brain Inferior Temporal Lobe	brain
30	chr5:80255200-80255400	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
31	chr5:80255200-80255400	Enhancers	Brain Substantia Nigra	brain
32	chr5:80255200-80255400	Bivalent Enhancer	Fetal Kidney	kidney
33	chr5:80255200-80255600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
34	chr5:80255200-80255600	Bivalent/Poised TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
35	chr5:80255200-80255600	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
36	chr5:80255200-80255600	Bivalent Enhancer	Brain Hippocampus Middle	brain
37	chr5:80255200-80255600	Bivalent Enhancer	Fetal Brain Female	brain
38	chr5:80255200-80255600	Bivalent Enhancer	Left Ventricle	heart
39	chr5:80255200-80255600	Enhancers	Right Atrium	heart
40	chr5:80255200-80255600	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
41	chr5:80255200-80255600	Enhancers	NHLF	lung
42	chr5:80255200-80255800	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
43	chr5:80255200-80255800	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
44	chr5:80255200-80255800	Bivalent Enhancer	Thymus	Thymus
45	chr5:80255200-80256000	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
46	chr5:80255200-80256000	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
47	chr5:80255200-80256000	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
48	chr5:80255200-80256000	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
49	chr5:80255200-80256000	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
50	chr5:80255200-80256600	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links